Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1135 of 5804
-
Zapping the brain after stroke may stop pain before it starts
Prevention Not yet recruitingThis is a prospective clinical study to evaluate the efficacy of tDCS stimulation, coupled with conventional rehabilitation, on the development of post-stroke neuropathic pain. The study involves a double-blind, randomized, sham-controlled experimental protocol involving 2 paral…
Phase: NA • Sponsor: University Hospital, Clermont-Ferrand • Aim: Prevention
Last updated Jun 27, 2026 08:06 UTC
-
Can a nerve drug speed burn healing? new trial aims to find out
Disease control Recruiting nowMany patients suffer from traumatic burns and current treatments do not increase the regenerative potential of either skin grafts or the remaining uninjured skin. There is a need to develop treatments to accelerate and improve healing of burn injuries. More research is needed to …
Phase: PHASE2 • Sponsor: John Elfar • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
AI and blood tests join forces to crack the code of hormone disorders
Diagnosis Not yet recruitingHyperandrogenism is a common reason for consultation, the causes of which can range from common conditions (PCOS) to rarer conditions with major genetic implications (NC21OHD). It is characterized by elevated levels of circulating androgens, mainly testosterone. This excess of an…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 08:01 UTC
-
Diabetes drug metformin could help heal spinal cord injuries
Disease control Not yet recruitingBackground: Spinal cord injury (SCI) is a major global health problem, with thoraco-lumbar injuries often leading to paraplegia and incomplete neurological recovery. The glial scar, resulting from astrocyte activation at the injury site, constitutes a major barrier to axon regen…
Phase: PHASE4 • Sponsor: Badr University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Sound waves boost chemo to fight liver tumors in pancreatic cancer patients
Disease control Not yet recruitingThis is a phase I study that will enroll patients with pancreatic cancer and liver metastasis who have failed prior gemcitabine-based chemotherapy. Patients will be treated with nanoliposomal irinotecan plus 5-FU and leucovorin and NH002-based sonoporation to the liver metastasis…
Phase: PHASE1 • Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Glowing dye guides surgeons to precise liver cancer removal
Disease control Recruiting nowThis prospective, single-arm exploratory study evaluates the feasibility and safety of a novel ICG-Cisplatin self-assembled nanoprobe (NIR-II NanoM) for fluorescence-guided surgery in patients with Hepatocellular Carcinoma (HCC). Participants will receive a transarterial injectio…
Phase: EARLY_PHASE1 • Sponsor: West China Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Poop pills may reboot liver cancer therapy
Disease control Recruiting nowThe purpose of this study is to evaluate whether fecal microbiota transplantation (FMT), when administered in combination with atezolizumab and bevacizumab, can improve treatment response in participants with hepatocellular carcinoma (HCC) whose disease has progressed during prio…
Phase: PHASE2 • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Glowing dye could guide safer cancer surgery
Diagnosis Not yet recruitingSentinel lymph nodes, as the primary site of tumor metastasis, play a pivotal role in assessing patient prognosis and planning subsequent treatment strategies. The investigators plan to conduct a multicenter, prospective cohort study to evaluate the effectiveness of indocyanine g…
Phase: PHASE3 • Sponsor: Fujian Medical University Union Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
New pill aims to ease sickle cell anemia without pain crises
Disease control Not yet recruitingSIL-8301 (senicapoc) is being developed for the chronic treatment of patients with sickle cell disease in both adults and children. The purpose of this study is to compare the effects of senicapoc to placebo in patients with sickle cell disease that have had fewer than 2 acute si…
Phase: PHASE2 • Sponsor: Biossil Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Turmeric power: could curcumin ease chemo side effects for rectal cancer patients?
Symptom relief Not yet recruitingThis clinical study investigates the anti-inflammatory and anti-cancer properties of a high-bioavailability formulation of curcumin (BCM-95) in patients with mid-to-low rectal cancer receiving neoadjuvant chemoradiotherapy (nCRT). Curcumin, a polyphenolic compound derived from Cu…
Phase: PHASE2 • Sponsor: Chang Gung Memorial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
AI could stop diabetic foot ulcers from returning
Knowledge-focused Not yet recruitingDiabetes is one of the major chronic diseases, and diabetic foot ulcer (DFU) is a significant adverse prognosis of diabetes. The recurrence of DFU after healing involves multiple risk factors, such as changes in foot loading patterns, patient compliance, family care capacity, blo…
Sponsor: Peking University Third Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Light therapy shows promise against HPV-Linked cervical precancer
Disease control Not yet recruitingThis multicenter, prospective trial assesses ALA-PDT versus observation for efficacy and safety in treating cervical LSIL with HPV16/18 infection.
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
VR hypnosis offers new hope for sleep in young cancer survivors
Symptom relief Not yet recruitingThe study aims to examine the effectiveness of virtual reality (VR) hypnosis for improving sleep in among Chinese childhood cancer survivors. Investigators will conduct a three-arm mixed-methods randomized controlled trial (RCT) among 186 Chinese Childhood Cancer Survivors (CCCs)…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Heart patients to test app-based care for better blood pressure and cholesterol control
Disease control Not yet recruitingThe DigiCare-CHD study is an investigator-initiated, multicenter, open-label, parallel-group randomized controlled trial. It aims to evaluated the efficacy of a smartphone-based digital remote management platform compared to usual care in achieving dual goal attainment of blood p…
Phase: NA • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for rare blood cancers: drug cocktail targets tough lymphomas
Disease control Not yet recruitingThis is a prospective, multicenter, open-label, phase Ib/II clinical study to evaluate the safety and efficacy of EZH2 inhibitor Zeprumetostat in combination therapy for patients with relapsed or refractory mature T-cell and NK-cell lymphomas.
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Behavioral boost: new study tests if counseling extends life in liver cancer
Symptom relief Not yet recruitingResearch purpose 1. To evaluate the impact of complex behavioral intervention on the one-year overall survival rate of patients with unresectable liver cancer after comprehensive treatment, a comparative study was conducted between the complex behavioral intervention group and t…
Phase: NA • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Sleep showdown: HRT vs. CBT for menopausal insomnia
Symptom relief Recruiting nowThe goal of the clinical trial is to learn if Hormone Replacement Therapy (HRT) and Cognitive Behavioral Therapy (CBT-I) can treat insomnia in menopausal women. The main questions it aims to answer are: * Are HRT and CBT-I effective in reducing insomnia in menopausal women? * Ar…
Phase: PHASE4 • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Could a common supplement help hearts pump better?
Disease control Recruiting nowThis study is a multicenter, double-blind, randomized controlled Phase 2 trial designed to evaluate the safety and efficacy of Ademetionine in patients with obstructive hypertrophic cardiomyopathy (oHCM). The study will recruit patients with oHCM who, under double-blind condition…
Phase: PHASE2 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New AR game aims to keep aging brains sharp
Prevention Recruiting nowBackground: Multidomain, technology-based interventions represent a promising approach to dementia prevention by simultaneously targeting cognitive, physical, and social domains. Exercogs® is a novel exergaming platform combining augmented reality (AR) and gamification, designed …
Phase: NA • Sponsor: Eduarda Oliosi, MS • Aim: Prevention
Last updated Jun 27, 2026 12:07 UTC
-
Healing heel bone infections: could an antibiotic bone graft be the key?
Disease control Recruiting nowThe ACHILLS Trial is a multicentre randomised controlled feasibility study comparing partial calcanectomy with and without the use of an antibiotic-impregnated bone graft substitute (Cerament G) for treating calcaneal osteomyelitis, specifically on wound healing rates, re-infecti…
Phase: NA • Sponsor: Royal College of Surgeons, Ireland • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC